TY - JOUR
KW - Substance Use Disorders -- Drug Therapy -- In Pregnancy
KW - Treatment Outcomes
KW - Pregnancy Outcomes
KW - Buprenorphine -- Therapeutic Use
KW - Naloxone -- Therapeutic Use
KW - Drug Therapy, Combination
KW - Human
KW - Prospective Studies
KW - Retrospective Design
KW - Pregnancy
KW - Female
KW - Descriptive Statistics
KW - Data Analysis Software
KW - Confidence Intervals
KW - Odds Ratio
KW - Chi Square Test
KW - Mann-Whitney U Test
KW - Fisher's Exact Test
KW - T-Tests
KW - Logistic Regression
KW - Adult
AU - Nathan Mullins
AU - Shelley L. Galvin
AU - Melinda Ramage
AU - Marie Gannon
AU - Kathleen Lorenz
AU - Brent Sager
AU - Carol C. Coulson
A1 - 
AD - Department of Obstetrics and Gynecology, Mountain Area Health Education Center, Asheville, NC; Department of Research, UNC Health Sciences at MAHEC, Asheville, NC; Department of Obstetrics and Gynecology, UNC-Chapel Hill School of Medicine, Chapel Hill, NC; OB/GYN Residency Program, Mountain Area Health Education Center, Asheville, NC
BT - Journal of Addiction Medicine
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 3
CY - Baltimore, Maryland
DO - 10.1097/ADM.0000000000000562
IS - 3
JF - Journal of Addiction Medicine
LA - English
M1 - Journal Article
PB - Lippincott Williams & Wilkins
PP - Baltimore, Maryland
PY - 2020
SN - 1932-0620
SP - 185
EP - 192
EP - 
T1 - Buprenorphine and Naloxone Versus Buprenorphine for Opioid Use Disorder in Pregnancy: A Cohort Study
T2 - Journal of Addiction Medicine
TI - Buprenorphine and Naloxone Versus Buprenorphine for Opioid Use Disorder in Pregnancy: A Cohort Study
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1097/ADM.0000000000000562
VL - 14
VO - 1932-0620
Y1 - 2020
Y2 - May
ER -